Skip to main content
SpringerLink
Log in

Lidocaine 5% medicated plaster [Versatis] has been approved for restricted use within the NHS Scotland

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Grunenthal Ltd.Shingles Pain Treatment Will Benefit More Patients. Media Release: 21 Aug 2008. Available from: URL: http://www.grunenthal.co.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lidocaine 5% medicated plaster [Versatis] has been approved for restricted use within the NHS Scotland. Pharmacoecon. Outcomes News 561, 10 (2008). https://doi.org/10.2165/00151234-200805610-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805610-00030

Keywords

Search

Navigation